Redeye comments on Scandion communicating CORIST part 2 top-line results. While we judge that top-line results confirm safety and tolerability of combining SCO-101 and FOLFIRI, no partial responses have been observed thus far. Therefore, we judge that CORIST part 2 top-line data are incrementally negative.